Credits Available: 4.75 hours of AMA PRA Category 1 Credit™ with ABIM MOC

Description: This curriculum is designed to enhance knowledge, competence, and confidence among oncology clinicians regarding second-line therapy for small cell lung cancer (SCLC). Learners will explore evidence-based treatment sequencing, adverse event management, and emerging clinical trial data to optimize patient outcomes.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Oncology, Hematology/Oncology
I am a medical oncologist who specializes in caring for people with lung cancer. As an active member of the Thoracic Disease Management Team, I collaborate with specialties including radiation oncology, thoracic surgery, pathology, and interventional radiology. Together, we ensure that we provide extraordinary individualized care. My colleagues and I are committed to addressing not only each person’s disease, but also their unique social circumstances, priorities, and beliefs.

I am particularly interested in using precision medicine when planning treatment. This personalized approach allows us to provide the highest quality of care all closer to home at MSK Bergen, where I practice